[go: up one dir, main page]

FI953956L - 2,3-ringkondenserade 1,4-dihydropyridiner, förfaranden för framställning av dessa och användning av dessa som läkemedel - Google Patents

2,3-ringkondenserade 1,4-dihydropyridiner, förfaranden för framställning av dessa och användning av dessa som läkemedel Download PDF

Info

Publication number
FI953956L
FI953956L FI953956A FI953956A FI953956L FI 953956 L FI953956 L FI 953956L FI 953956 A FI953956 A FI 953956A FI 953956 A FI953956 A FI 953956A FI 953956 L FI953956 L FI 953956L
Authority
FI
Finland
Prior art keywords
dihydropyridines
pharmaceuticals
fused
preparation
ring
Prior art date
Application number
FI953956A
Other languages
English (en)
Finnish (fi)
Other versions
FI953956A0 (sv
Inventor
Klaus Urbahns
Siegfried Goldmann
Hans-Georg Heine
Bodo Junge
Rudolf Schohe-Loop
Henning Sommermeyer
Thomas Glaser
Reilinde Witka
Vry Jean-Marie-Viktor De
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI953956A0 publication Critical patent/FI953956A0/sv
Publication of FI953956L publication Critical patent/FI953956L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI953956A 1994-08-25 1995-08-23 2,3-ringkondenserade 1,4-dihydropyridiner, förfaranden för framställning av dessa och användning av dessa som läkemedel FI953956L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4430092A DE4430092A1 (de) 1994-08-25 1994-08-25 2,3-Cyclisch kondensierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (2)

Publication Number Publication Date
FI953956A0 FI953956A0 (sv) 1995-08-23
FI953956L true FI953956L (sv) 1996-02-26

Family

ID=6526497

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953956A FI953956L (sv) 1994-08-25 1995-08-23 2,3-ringkondenserade 1,4-dihydropyridiner, förfaranden för framställning av dessa och användning av dessa som läkemedel

Country Status (15)

Country Link
US (1) US6121284A (sv)
EP (1) EP0705830A1 (sv)
JP (1) JPH0859622A (sv)
KR (1) KR960007594A (sv)
CN (1) CN1127250A (sv)
AU (1) AU3011095A (sv)
CA (1) CA2156672A1 (sv)
CZ (1) CZ217495A3 (sv)
DE (1) DE4430092A1 (sv)
FI (1) FI953956L (sv)
HU (1) HU218209B (sv)
IL (1) IL115029A0 (sv)
NO (1) NO953321L (sv)
PL (1) PL310147A1 (sv)
SK (1) SK104495A3 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
WO2000024741A2 (en) * 1998-10-28 2000-05-04 Abbott Laboratories Dihydropyridine compounds and their use as potassium channel openers
US6538004B2 (en) 2000-03-03 2003-03-25 Abbott Laboratories Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
WO2001066544A2 (en) * 2000-03-03 2001-09-13 Abbott Laboratories Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
US20050075359A1 (en) * 2003-03-14 2005-04-07 Rikako Kono Large conductance calcium-activated K channel opener
EP1663227A2 (en) * 2003-09-10 2006-06-07 Synta Pharmaceuticals Corporation Dihydropyridine compounds for treating or preventing metabolic disorders
EP2392328A1 (en) * 2005-05-09 2011-12-07 Hydra Biosciences, Inc. Compounds for modulating TRPV3 Function
US8916550B2 (en) * 2005-05-09 2014-12-23 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
US9012217B2 (en) * 2008-09-17 2015-04-21 Burnham Institute For Medical Research Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells
US9233926B2 (en) * 2008-09-17 2016-01-12 Sanford-Burnham Medical Research Institute Compounds for stem cell differentiation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
US4021434A (en) * 1972-01-22 1977-05-03 Yamanouchi Pharmaceutical Co., Ltd. Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate
GB1430961A (en) 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3443678A1 (de) * 1984-11-30 1986-06-05 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 4-acyloxy-3-oxo-buttersaeureestern
DE3521761A1 (de) * 1985-06-19 1987-01-02 Bayer Ag Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE3629545A1 (de) * 1986-08-30 1988-03-10 Bayer Ag Dihydropyridinverbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester

Also Published As

Publication number Publication date
IL115029A0 (en) 1995-12-08
AU3011095A (en) 1996-03-07
NO953321L (no) 1996-02-26
HU9502503D0 (en) 1995-10-30
CN1127250A (zh) 1996-07-24
CZ217495A3 (en) 1996-03-13
NO953321D0 (no) 1995-08-24
SK104495A3 (en) 1996-06-05
EP0705830A1 (de) 1996-04-10
KR960007594A (ko) 1996-03-22
HU218209B (hu) 2000-06-28
PL310147A1 (en) 1996-03-04
HUT74615A (en) 1997-01-28
JPH0859622A (ja) 1996-03-05
FI953956A0 (sv) 1995-08-23
US6121284A (en) 2000-09-19
DE4430092A1 (de) 1996-02-29
CA2156672A1 (en) 1996-02-26

Similar Documents

Publication Publication Date Title
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
FI955235L (sv) Oxazolidindionderivat, deras framställning och användning
FI964395L (sv) Nya erytromycinderivater, förfarande för framställning av dessa och deras användning som läkemedel
FI955913A0 (sv) Nya erytromycinderivat, förfaranden för deras framställning och deras användning som läkemedel
EE03680B1 (et) Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid
FI972313L (sv) Nya 2,3-diketopiperazinderivat och deras salter
FI951468L (sv) Lipopeptidderivat, förfarande för framställning och användning av desamma
FI935465L (sv) Termoplastisk komposition, foerfarande foer framstaellning av denna och anvaendning av denna
EE9800265A (et) Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
FI951817L (sv) Organolluminoxyprodukt, dess framställning och användning
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE9800200A (et) Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
FI970095L (sv) Nya kemiska föreningar, deras framställning och deras användning som läkemedel
EE9800145A (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
EE04398B1 (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
FI953956L (sv) 2,3-ringkondenserade 1,4-dihydropyridiner, förfaranden för framställning av dessa och användning av dessa som läkemedel
FI941914A0 (sv) 2-amino-4-kinolindihydropyridiner, förfaranden för framställning av dessa och användning av dessa
FI951631L (sv) Substituerade kynureniner, förfarande för deras framställning och använding av desamma som läkemedel
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
FI960316A0 (sv) Oxatiolaner, förfarande för deras framställning och farmaceutiska kompositioner innehållande desamma
FI955679A0 (sv) Piperidinderivater, framställning och användning därav
FI941912L (sv) 3-kinolylsubstituerade dihydropyridiner, förfarande för framställning av dessa samt använding av dessa i läkemedel
FI971081L (sv) Triazolopyridaziner, förfarande och mellanprodukter för framställning av dessa samt användning av dessa som läkemedel